A

Ardelyx
D

ARDX

4.75000
USD
-0.07
(-1.35%)
Market Open
Volume
17,467
EPS
-0
Div Yield
-
P/E
-15
Market Cap
1,122,689,240
OverviewSignalsIdeasNews
Related Instruments
    A
    ADMP
    0
    (0%)
    0.000000 USD
    ALNY
    ALNY
    -4.430
    (-1.80%)
    241.075 USD
    B
    BPMC
    -0.960
    (-1.07%)
    89.160 USD
    C
    CRBP
    -0.260
    (-2.01%)
    12.700 USD
    D
    DVAX
    0.140
    (1.10%)
    12.860 USD
    G
    GLMD
    -0.14000
    (-4.42%)
    3.03000 USD
    G
    GTHX
    0.01000
    (0.14%)
    7.16000 USD
    V
    VKTX
    -0.670
    (-1.59%)
    41.600 USD
    Z
    ZYNE
    0
    (0%)
    0.000000 USD
    More
News

Title: Ardelyx

Sector: Healthcare
Industry: Biotechnology
Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.